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ABSTRACT
The increase in antibacterial resistance has placed the issue of microbial multi-drug
resistance on a global stage (Gurunathan, 2019). This issue poses a threat to human and animal
health as well as to the environment (Aslam et al., 2018). It affects not only the efficacy of
treatment but also how those treatments are conducted (Friedman, Temkin, & Carmeli, 2016). As
a result of this ongoing threat, new treatments that have potent effects on bacteria are necessary.
One scientific response to this issue has been the development of multifunctional nanoparticles
(NPs)(H. Wang et al., 2018). NPs have the ability to be utilized by its varying modes of action and
compatibility with other forms of treatments (Alavi & Rai, 2019). This advantage, when
successful, would allow for the lowering of dosage and frequency of treatments required to achieve
bacteria killing (Alavi & Rai, 2019).
Despite a plethora of proposed designs for the improvement of antibacterial treatment,
questions remain concerning the mode of action of these new agents. The aim of this study is to
develop a protocol facilitating the identification of modes of action of newly formulated
antibacterial agents. Our hypothesis is that different modes of action will have distinct effects on
the morphology and composition of the cells. To test this, we characterized the structural, physical
and molecular changes of a model system, E. coli., before and after treatments using antibiotics
with known modes of action. We selected two bactericidal antibiotics: colistin which is a
membrane disrupting antibiotic, and streptomycin which is a protein inhibiting antibiotic (SantoDomingo, Chareyron, Broenimann, Lassueur, & Wiederkehr, 2017; Sun et al., 2019;
Thummeepak, Kitti, Kunthalert, & Sitthisak, 2016). We discuss the protocol development and the
significant differences observed in the bacterial responses as well as the limitations of the
ii

envisioned approach. We conclude by providing a perspective of the impact our findings are
expected to have on evaluating new engineers NP treatments.
Keywords: E. coli, Raman Spectroscopy, FTIR, AFM, bacteria

iii

ACKNOWLEDGEMENTS
I would firstly like to thank my thesis chair, Dr. Laurene Tetard for allowing me the
opportunity to be a part of her research team. Dr. Tetrad’s dedication to research and her strong
work ethic provided a research environment that pushed me to think critically but also allowed me
to foster and develop my ideas. It is through her mentorship and guidance that she allowed me to
expand my research ideas. She ensured I had all the tools necessary to see this project through and
this has been one of the most pivotal learning experiences.
The completion of this project was propelled by contributions from other research teams.
I would also like to extend special gratitude to my committee members: Dr. Swadeshmukul Santra
and Dr. Ellen Kang whose expertise help me polish and refine my work. I would like to give special
thanks to the members of Dr. Santra’s team for always making room in their lab and working
alongside me to ensure I had the tools needed to complete this project. The contribution of my
team member played a vital role in my research experience. I would like to thank Briana Lee,
Chance Barrett and Fernand Torres Davila who tirelessly helped to train me on all the
characterization instruments, listened to my ideas and always provided constructive feedback for
this project. I would like however, to single out the contributions of Briana Lee to this project. She
took me under her wing as her protégé, provided a framework for the various parts of this project
and supplemented my knowledge of the bacteria specific portions of this project.
Lastly, I would like to tip my hat to my friends and family for their invaluable support. It
was their efforts in the background that in so many ways continuously kept me going.

iv

Table of Contents
LIST OF TABLES ........................................................................................................................ vii
LIST OF FIGURES ..................................................................................................................... viii
CHAPTER ONE: INTRODUCTION ............................................................................................. 1
1.1 Introduction and Aim ............................................................................................................ 1
1.2 Bacteria and their Structure ................................................................................................... 3
1.3 Conventional antibiotics and their modes of action .............................................................. 5
1.3.1 Background ..................................................................................................................... 5
1.3.2 Inhibition of cell membrane function with Colistin ....................................................... 6
1.3.3 Inhibition of protein synthesis with Streptomycin ......................................................... 7
1.4 Hypothesis of the work ......................................................................................................... 8
CHAPTER TWO: CHARACTERIZATION TOOLS .................................................................... 9
2.1 Introduction ........................................................................................................................... 9
2.2 Instrumentation – Principle of the techniques ....................................................................... 9
2.2.1 Atomic Force Microscopy (AFM) .................................................................................. 9
2.2.2 Raman Spectroscopy .................................................................................................... 10
2.2.3 Fourier Transform Infrared Spectroscopy .................................................................... 12
CHAPTER THREE: EXPERIMENTAL METHODS ................................................................. 15
3.1 Bacteria Growth .................................................................................................................. 15
3.2 Bacteria Treatment .............................................................................................................. 15
3.2.1 Minimum Inhibitory Concentration.............................................................................. 15
3.2.2 Bacterial Treatment ...................................................................................................... 16
3.2.3 Sample preparation for imaging and spectroscopy....................................................... 16
3.3 Instrumental Setup............................................................................................................... 17
3.3.1 AFM Measurements ..................................................................................................... 17
3.3.2 Raman Spectroscopy Measurements ............................................................................ 17
3.3.3 FTIR Measurements ..................................................................................................... 18
3.3.4 Statistical analysis......................................................................................................... 19
CHAPTER FOUR: EXPERIMENTAL RESULTS ..................................................................... 20
4.1 Morphology and roughness of the bacteria evaluated by AFM .......................................... 20
4.2 Composition of the bacteria investigated by infrared spectroscopy ................................... 26
v

4.2.1. Raman and IR signatures of E. Coli ............................................................................ 26
4.2.2. Peak deconvolution...................................................................................................... 32
4.2.3. Principal Component Analysis .................................................................................... 36
Chapter 5: Conclusion................................................................................................................... 39
REFERENCES ............................................................................................................................. 41

vi

LIST OF TABLES
Table 1. Summary of changes in the mean length of untreated and treated E. coli. ............ 21
Table 2. Summary of changes in the mean width of untreated and treated E. coli. ............. 22
Table 3. Summary of changes in the mean width of untreated and treated E. coli. ............. 23
Table 4. Statistical significance of p-tests with treated and untreated samples for (a) length,
(b) width, and (c) surface roughness. For all sample 1 represents statistical significance and 0
represents no statistical significance. ............................................................................................ 24
Table 5. Summary of the Raman modes detected for untreated E. coli. ............................... 27
Table 6. Bands of untreated and treated E. coli. From Raman spectra for both the 1000-1700
cm-1 and 1000-3500 cm-1 range, where X represents that the band was unchanged. .................... 28
Table 7. Summary of the IR modes detected for untreated E. coli. ....................................... 30
The spectrum (Figure 13(a)) reveals the IR active compounds of untreated E. coli. There appears
to be signals from varous bonds, including P=O [79], as well as bands related to lysaccharides
and amides, similar to Raman spectra. Bacterial polysaccharides are usually associated with
bacterial cell wall and membrane and amide stutures help classify the state of proteins of the
bacteria [80]. Additonal stutures such as the C=N and CH2 bending of lipids were present. The
C-H stretching vibration can sometimes be used to gain information on the state of the freedom
of motion and fatty acyl order [81]. A summary of the bands is provided in Table 8. Table 8.
Bands of untreated and treated E. coli. X represents the same band as the untreated. ........... 30
Table 9. Summary of the Raman Peak Deconvolution. (a) Relative Raman shift of
comparison of compound in untreated with those of treatment, (b) Potential Raman shift of bands
(not present in untreated) that occur due to 2 hours incubated colistin treatment, and (c) Potential
Raman shift of bands (not present in untreated) that occur due to 4 hours incubated streptomycin
treatment. ...................................................................................................................................... 32
Table 10. Wavenumber shift for FTIR peak deconvolution. (a) FTIR wavenumber
comparison of compound in untreated with those of treatment, (b) Potential assignment of FTIR
bands (not present in untreated) that occur due to 2 hours incubated colistin treatment, and (c)
Potential assignment of FTIR bands (not present in untreated) that occur due to 4 hours
incubated streptomycin treatment. ................................................................................................ 34

vii

LIST OF FIGURES
Figure 1. E. coli structure (left) and cell wall composition (right). E. coli is composed of a
cell body and a flagellum. A cell envelope surrounds the cytoplasm. The cell wall which is
composed of the inner membrane, the periplasm and the outer membrane. The inner membrane
consists of a symmetric lipid bilayer composed of phospholipids and membrane proteins. The
periplasm contains the peptidoglycan cell wall. The outer membrane is an asymmetric lipid
bilayer encompassing a layer of phospholipids on the side of the periplasm and
lipopolysaccharide (LPS) on the outermost layer. The outer membrane also contains proteins but
with different secondary conformations. The inner and outer membranes are both anchored in the
periplasm with lipoproteins............................................................................................................. 3
Figure 2. AFM principle. The AFM setup encompasses a cantilever, laser source, photodiode
detector, and controller. An AFM image is created by engaging the cantilever tip with the surface
of the sample. In contact mode, engaging the tip corresponds to reducing the tip-sample distance
to enter the repulsive force regime. Once engaged, the tip is scanned across the region of interest.
The deflection of the cantilever is monitored using a read-out laser reflected off the back of the
cantilever to a position sensitive detector. The voltage of the detector is recorded in Volts and
converted into a Height image. ..................................................................................................... 10
Figure 3. Raman Spectroscopy Setup including the excitation laser (532nm), the objective for
focusing and collecting light, the notch filter to block elastically scattered light and the
spectrometer to analyze the Raman signal. The data is collected by a CCD detector in the
spectrometer. ................................................................................................................................. 12
Figure 4. FTIR Spectroscopy (a) and ATR configuration (b). FTIR spectroscopy consists in
using mid-infrared light to illuminate a sample and studying the absorbed energies by monitoring
the signal with an IR detector. The setup includes a Michelson interferometer as a mean to
introduce an intensity modulation and interference pattern that can be used to obtain the full IR
spectrum in the 400-4000cm-1 range in a short collection time. The ATR configuration allows for
liquid measurement was using the concept of evanescent waves to probe the sample at the
interface of the ATR crystal. The total internal reflected wave contains the information of the
sample. .......................................................................................................................................... 13
Figure 5. Raman Spectra of Substrates with Untreated E. coli samples (a) Untreated E. coli
on calcium fluoride substrate, (b) Untreated treated E. Coli on gold coated glass substrate (c) E.
coli on silicon substrate. ................................................................................................................ 18

viii

Figure 6. AFM Images of untreated and treated E. coli. (a) Untreated E. coli 50x50 μm and
5x5 μm images, (b) Colistin treated E. coli 50x50 μm and 5x5 μm images with 2-hour incubation
period, and (c) Streptomycin treated E. coli 50x50 μm and 5x5 μm images with 4-hour
incubation period. ......................................................................................................................... 20

Figure 7. Histograms of length measurement from AFM scans for untreated and treated E.
coli. (a) Frequency of length associated with untreated E. coli, (b) Frequency of length associated
with colistin treated E. coli with 2 hours incubation period and (c) Frequency of length
associated with streptomycin treated E. coli with 4 hours incubation period. .............................. 21
Figure 8. Histogram of width measurements from AFM scans for untreated and treated E.
coli. (a) Frequency of width associated with untreated E. coli, (b) Frequency of width associated
with colistin treated E. coli with 2 hours incubation period and (c) Frequency of width associated
with streptomycin treated E. coli with 4 hours incubation period. ............................................... 22

Figure 9. Histogram of surface roughness from AFM scans for untreated and treated E.
coli. (a) Frequency of surface roughness associated with untreated E. coli, (b) Frequency of
surface roughness associated with colistin treated E. coli with 2 hours incubation period and (c)
Frequency of surface roughness associated with streptomycin treated E. coli with 4 hours
incubation period. ......................................................................................................................... 23
The study of the physical traits of E. Coli suggests that both mode of actions affect the size and
surface roughness of the cells, although streptomycin, the protein inhibiting treatment, seems to
have a slightly higher effect (Figure 10). It showed a greater reduction in both width, length and
surface roughness measurements. Next we detail our evaluation of the data using Analysis of
variance (ANOVA) to determine statistical significance of the differences observed (Table 4).

ix

...

Figure

10. Box Plots of length, width and surface roughness distributions for untreated and
treated E. coli. For all samples the box represents the 25th to 75th percentile, whiskers indicate
the standard deviation and the middle square shows the mean. (a) Length distribution of treated
and untreated E. coli, (b) Width distribution of treated and untreated E. coli (c) Surface
roughness distribution of treated and untreated E. coli................................................................. 24

Figure 11.
Raman spectra of untreated E. coli. (a)Untreated bacteria for spectral range of 1000-3500 cm-1
and (b) Untreated bacteria for spectral range of 1000-1700 cm-1. ................................................ 27

Figure 12. Raman
spectra of untreated and treated E. coli. (a) Untreated and treated bacteria with no incubation
with formulation of treatment for spectral range of 1000-3500 cm-1 and (b) Untreated and treated
bacteria with formulation of treatment for spectral range of 1000-1700 cm-1 ............................... 28
x

Figure 13.
FTIR spectra of untreated and treated E. coli. (a)Untreated bacteria with no incubation with
formulation of treatment for spectral range of 1000-1700 cm-1 and (b) Untreated and treated
bacteria with formulation of treatment for spectral range of 1000-1750 cm-1 .............................. 30
Figure 14. Raman peak deconvolution for untreated and treated E. coli. (a)Untreated
bacteria with no incubation with formulation of treatment, (b) Colistin treated bacteria with 2
hours incubation period formulation of treatment, and (c) Streptomycin treated bacteria with 4
hours incubation period formulation of treatment. ....................................................................... 32
Figure 15. FTIR peak deconvolution for untreated and treated E. coli. (a)Untreated bacteria
with no incubation with formulation of treatment, (b) Colistin treated bacteria with 2 hours
incubation period formulation of treatment, and (c) Streptomycin treated bacteria with 4 hours
incubation period formulation of treatment. ................................................................................. 34

Figure
16. Principal Component Analysis for untreated and treated E. coli for Raman scans. (a)
Comparison of loadings for principal component loadings 1 and 2 (b) Distribution of untreated
and treated bacteria with respect to Principal Component 1 and 2 ............................................... 37

xi

Figure 17. Principal Component Analysis for untreated and treated E. coli for FTIR scans.
(a) Comparison of loadings for principal component loadings 1&2 (b) Distribution of untreated
and treated bacteria with respect to Principal Component 1 and 2 ............................................... 38

xii

CHAPTER ONE: INTRODUCTION
1.1 Introduction and Aim
Antibacterial resistance has emerged as a serious and far reaching issue (Aslam et al., 2018;
Fair & Tor, 2014; Friedman et al., 2016; Ibrahim, Mattar, Abdel-Khalek, & Azzam, 2017;
Rehm & Weber, 2007)with implications far beyond the immediate issues of morbidity and
mortality (Doi et al., 2017). In addition to the impacts already experienced in hospitals and
medicine, the significant reliance on antibiotics in agriculture is expected to lead to new threats
related to food production in the near future. In agriculture, antibiotics are used for treating
diseases of plants and animals, including for handling simple infection or for more serious
cases such as post-operative care (Chang, Wang, Regev-Yochay, Lipsitch, & Hanage, 2015;
McManus, Stockwell, Sundin, & Jones, 2002). Alongside the natural adaptation of bacteria,
the mis-use and misdoing of antibiotic treatments have accelerated the need for new solutions
to overcome bacterial resistance (Rashid et al., 2019; Shallcross & Davies, 2014). Each
antibiotic is developed with a specific mode of action, which defines the manner in which it
will inhibit bacteria. Typical targets of the mode of action of antibiotics include: cell wall
synthesis, translational machinery and DNA replication (L. L. Wang, Hu, & Shao, 2017). Once
a bacterial strain develops tolerance or resistance to a given mode of action, increasing the dose
or frequency of the treatment is not a sustainable solution. This can be seen with the current
accumulation of Copper (Cu) in soil resulting from increasing the treatment concentration and
frequency in fields in an effort to manage developing diseases. In addition to showing little
improvement in managing diseases, such accumulation often brings about new issues such as
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leaching in surrounding waters and affecting the microbiomes of interconnected ecosystems.
Treatments with new modes of actions must be developed as alternative solutions to these
emerging threats. However, the development, assessment and registration of such antibacterial
formulation is tedious and lengthy.
As a solution to this problem scientists have been increasingly considering the use of
nanoparticles (NPs) to tailor drug with high efficacy and faster response times (Alavi & Rai,
2019; Baptista et al., 2018b; Gurunathan, 2019; H. Wang et al., 2018). Recent studies have
revealed a potential for high efficacy of nanoparticles in treating bacteria when used as carriers
for drug delivery. The most attractive aspect of using NPs for drug delivery is their ability to
load a range of antibacterial cargos for delivery to the targeted systems (Baptista et al., 2018a).
NPs such as gold (Au), silver (Ag) copper (Cu) and zinc oxide (ZnO) have been highlighted
for either potential in fighting drug resistance (Hemeg, 2017). However, many of the modes of
action of nanoparticles and nanomaterials remain unknown.
Based on the impact of antibacterial resistance and the importance of antibiotic treatments
to medicine and agriculture, the overarching goals of the present study aims to develop suitable
characterization schemes that could later be used to evaluate the impact of engineered NPs on
bacteria-although this validation in out of the scope of the present study. In particular, we aim
to evaluate the impact of the treatment on the morphology and chemical signatures of bacteria,
to determine whether some (or all) could eventually be used as markers to monitor antibacterial
treatments and their modes of action on bacteria. To achieve this, we used a bacterial model,
Escherichia coli (E. Coli), treated with antibiotics with defined mode of action - namely
colistin and streptomycin. Physical and chemical responses of the cells such as chemical
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composition, length, width and surface roughness to the antibacterial treatments were recorded
and analyzed.
By establishing this benchmark, we expect to better understand structural and molecular
changes experienced by the same bacterial model system within the future.

1.2 Bacteria and their Structure
Bacteria are living single-cell organisms with dimensions in the range of 1-5 m. They are
prokaryotes, which means that they do not have a nucleus. They are found in a broad range of
environments from water, soils, food or human bodies. Classification of these bacteria is usually
done based on the properties of the cell walls, their shapes (round, rod-like, helicoidal, etc) and
sometimes their genetic makeup. For instance, bacteria can be classified as “gram-positive” and
“gram-negative”, which corresponds to their ability to retain the crystal violet dye during the
procedure of gram-staining (Blount, 2015).

Figure 1. E. coli structure (left) and cell wall composition (right). E. coli is composed of a cell body and a
flagellum. A cell envelope surrounds the cytoplasm. The cell wall which is composed of the inner membrane, the
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periplasm and the outer membrane. The inner membrane consists of a symmetric lipid bilayer composed of
phospholipids and membrane proteins. The periplasm contains the peptidoglycan cell wall. The outer membrane is
an asymmetric lipid bilayer encompassing a layer of phospholipids on the side of the periplasm and
lipopolysaccharide (LPS) on the outermost layer. The outer membrane also contains proteins but with different
secondary conformations. The inner and outer membranes are both anchored in the periplasm with lipoproteins.

Escherichia coli (E. coli) is common model system for gram-negative bacteria. It is an
essential organism that has been used to unveil many biological findings, such as cracking the
genetic code by revealing information about DNA transcription, translation and replication
(Blount, 2015).
As a gram-negative cellular system, E. Coli’s structure consists of two membranes each
made up of lipopolysaccharides that regulate the entry of substances into and out of the cell (Figure
1). Between these two membranes exists a thin peptidoglycan layer that allows for the cell to
maintain its rigid structure (Blount, 2015; Silhavy, Kahne, & Walker, 2010). The outermost layer
of the cell is composed of lipopolysaccharides (LPS) that are made up of polysaccharides and
lipids (Jann & Jann, 1987; Stahle & Widmalm, 2019). LPS act as a permeability barrier to cationic
antimicrobial peptides, which helps intracellular survival (Delcour, 2009; Stahle & Widmalm,
2019). LPS and polysaccharides also maintain the integrity of the cell structure. LPS is the primary
layer involved in the interaction of the bacterium with surfaces (Reyes, Suárez, Sierra, & Beswick,
2009). It has been shown that he host-pathogen interaction and the host immune evasion system
can be controlled by the polysaccharide (Aduse-Opoku et al., 2006).
Figure 1 (right panel) also shows that the outer membrane contains porins and
transmembrane proteins. Porins control the permeability of cell by governing the optimal nutrient
access across the membrane (Liu & Ferenci, 1998). They consist of channels that control the
diffusion of hydrophilic molecules between the environment and the periplasm. The
4

transmembrane proteins of the outer membrane contain beta folds that are usually arranged in an
antiparallel conformation. These have been ascribed, in part, to help E. coli withstand harsh
environments (Rollauer, Sooreshjani, Noinaj, & Buchanan, 2015). The periplasmic space
separates the outer membrane from the inner membrane and contains a gel like fluid (Miller &
Salama, 2018). The inner membrane encloses the cytoplasm and serves as a dynamic substructure
(Papanastasiou et al., 2013). The phospholipids provide a pathway for substances to move across
membranes (Barak & Muchova, 2013). Overall, the complexity and heterogeneous composition
of the bacterial cell wall is still a topic of ongoing research, in which even minor lipids are found
to play essential roles in cellular activities (De Kruijff, Killian, Rietveld, & Kusters, 1997; Luirink,
Yu, Wagner, & de Gier, 2012). Both the outer and inner structures together adapt to optimize
bacterial survival in variable and stress conditions (Rowlett et al., 2017). In particular, alterations
in membrane phospholipids have been shown to impair bacterial cellular structure and function,
as well as their mechanisms of adaptation to stress, including their ability of form biofilms (Rowlett
et al., 2017).

1.3 Conventional antibiotics and their modes of action
1.3.1 Background
Antibiotics can be classified based on the cellular system they affect. The classification is
also dependent on whether the antibiotic can induce cell death (bactericidal) or inhibit cell growth
(bacteriostatic) (Kohanski, Dwyer, & Collins, 2010). Common modes of action include inhibition
of cell wall synthesis (e.g. penicillin), inhibition of cell membrane function (e.g. colistin),
inhibition of protein synthesis (e.g. tetracycline, streptomycin), inhibition of nucleic acid synthesis
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(e.g. metronidazole) and inhibition of other metabolic processes such as the folic acid pathway
(Kohanski et al., 2010). Here we focus on comparing the effect of two modes of action of
bactericidal antibiotics: inhibition of cell membrane function –using colistin– and inhibition of
protein synthesis –using streptomycin.

1.3.2 Inhibition of cell membrane function with Colistin
Colistin, also known as polymyxin E, is a bactericidal antibiotic often used as a last resort
to treat Gram-negative bacteria, such as multidrug-resistant (MDR) gram-negative bacteria (Vaara,
2019). As MDR bacteria develop resistance against colistin treatments, some infections may be
left with no cure (Hinchliffe et al., 2017). However, reports of colistin resistance have been quite
rare. The few instances of prevalence of colistin-resistant bacteria (E. coli) that have been recently
reported include a study in Vietnam (Yamamoto et al., 2019) and a study on specific strains such
as Acinetobacter baumannii (Qureshi et al., 2015). We note that due to the ever-changing survival
mechanisms of bacteria such as chromosomal mutation, resistance is expected to rise (Hinchliffe
et al., 2017).
The interaction of colistin and a lipid membrane representative of gram-negative bacteria
has been investigated by various methods, including by Circular Dichroism (CD) spectroscopy
(Dupuy et al., 2018). The study revealed no significant differences in secondary structural changes
in the lipid membrane mimics, which ruled out protein conformational change as the cause of its
bactericidal activity (Dupuy et al., 2018). However, in membranes corresponding to gram-negative
bacteria, colistin slightly increased the stiffness and chain order, suggesting that it could displace
divalent cations leading to membrane perturbation (Dupuy et al., 2018). Colistin also interacted
with the lipopolysaccharide of the membrane of gram-negative bacteria with high affinity, which

6

was interpreted as a mechanism for the antibiotic to dock to the cell surface (Dupuy et al., 2018).
The final and most lethal action of colistin is the damage it causes to the cytoplasmic membrane
(Vaara, 2019). These studies indicate that colistin has a more primary effect on the outer membrane
of the bacteria cell although the activity can have several consequences on the living system. These
findings discussed in the literature provide support for the scenario of membrane disruption as a
mode of action for this antibiotic treatment (Dupuy et al., 2018; Vaara, 2019). These studies
constitute the basis for our selection of colistin a model to study the effect of membrane disruption
in E. Coli.

1.3.3 Inhibition of protein synthesis with Streptomycin
Streptomycin is another bactericidal antibiotic drug. It is commonly used to treat both
gram-positive and gram-negative bacteria in humans especially for tuberculosis (Grayson et al.,
2017), animals (Nicoletti, Lenk, Popescu, & Swenson, 1989) and plants such as for fire blight in
apple and pear trees (Aćimović, Zeng, McGhee, Sundin, & Wise, 2015). The primary mode of
action for streptomycin is the inhibition of protein synthesis by binding within the 30s ribosomal
subunit (Iscla, Wray, Wei, Posner, & Blount, 2014). This irreversible binding leads to bacterial
death via misreading of the mRNA template (Luzzatto, Apirion, & Schlessinger, 1968). The
difference in mode of action of streptomycin compared with colistin provides an interesting
comparison with which to identify resulting physical and chemical changes in E. Coli in our study.
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1.4 Hypothesis of the work
In this work, we formulated the hypothesis that two modes of action such as inhibiting
membrane function and inhibiting protein synthesis will have different effects on the morphology
and chemical changes of antibacterial-sensitive bacterial systems such as E. Coli. To test this
hypothesis, we established an experimental protocol encompassing evaluation of the morphology
and composition of E. Coli before and after treatment with 2 different antibiotics, colistin and
streptomycin.
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CHAPTER TWO: CHARACTERIZATION TOOLS
2.1 Introduction
We evaluated the dimensions and shape of the bacteria, their surface roughness, and
chemical composition. The characterization tools used for this study were selected by taking into
account the scale of the features to resolve and the properties of the sample. Bacteria are soft
flexible structure with dimensions below 5 m in length and 1 m in width. Although
measurements are carried out in dry conditions, to resolve changes in cell membrane roughness
one has to consider a tool capable of imaging sub-micrometer structures without the need to stain
the sample. Atomic Force Microscopy (AFM) was identified as a well-suited tool as it provides
nanoscale resolution of biological systems in their native environments. Similarly, to study the
composition of the bacteria and the changes occurring as a result of antibacterial treatments, we
elected to use Fourier Transform Infrared Spectroscopy (FTIR), which provides insight on the
behavior of the cell culture as an ensemble, and Raman confocal spectroscopy, which allows to
focus the excitation light onto a few bacteria at a time for a better understanding of the
heterogeneities of the cell responses within the ensemble.
2.2 Instrumentation – Principle of the techniques
2.2.1 Atomic Force Microscopy
AFM uses a cantilever with a sharp metal tip (probe) to scan over the surface of the sample.
The tip-sample interactions lead to cantilever deflection, which can be monitored using a read-out
laser to reconstruct the topography of the sample surface (Cheng et al., 2019). Over the years,
AFM has been exploited to reveal the sample’s molecular interaction, surface hydrophobicity,
surface charges and its other mechanical properties (Dufrene, 2014). Previous studies have used
9

AFM to determine the Young’s modulus of cells and its evolution upon treatments of bacterial
cells (Mathelie-Guinlet et al., 2018). In addition to this, AFM can probe the rigidity of the cell, its
height and longitudinal area when exposed to multiple antibiotic treatments (Li et al., 2016).
One common mode of AFM imaging is contact mode. In our study, contact mode with a
gentle applied load and a soft cantilever were used to image the bacteria. In contact mode, the
forces between the tip and the sample are predominantly repulsive due to the short tip-sample
distance. The system is setup to monitor changes in cantilever deflection as the cantilever rasters
the sample. The changes in deflection are monitored with the read-out laser (Figure 2) reflected
off the top layer of the cantilever and directed to a position sensitive detector (or photodiode). The
recorded signals (in Volts) are then converted into a Height image (in nm).

Figure 2. AFM principle. The AFM setup encompasses a cantilever, laser source, photodiode detector, and
controller. An AFM image is created by engaging the cantilever tip with the surface of the sample. In contact mode,
engaging the tip corresponds to reducing the tip-sample distance to enter the repulsive force regime. Once engaged,
the tip is scanned across the region of interest. The deflection of the cantilever is monitored using a read-out laser
reflected off the back of the cantilever to a position sensitive detector. The voltage of the detector is recorded in
Volts and converted into a Height image.

2.2.2 Raman Spectroscopy
Raman Spectroscopy uses inelastically scattered light resulting from light (usually in the
visible range)-matter interaction to reveal information about the molecular vibrations, and thus the
10

composition, of a sample (Chisanga, Muhamadali, Ellis, & Goodacre, 2019). The proportion of
inelastically scattered photons resulting from the interaction of visible excitation light with the
sample is extremely small (approximately one in 10 million). Thus, sufficient laser power and
integration time (time during which the CCD detector collects scattered photons) should be
selected to detect the signal from the sample. The excitation light in focused on the sample using
an objective (from 20x to 100x magnification). The same objective is used to collect the scattered
photons. Inelastic scattering results from excitation of the electrons in the sample from ground
state to a virtual state. For inelastic decay, some of the energy is exchanged with molecules and
excites vibrational modes of the chemical bonds. This energy “loss” corresponds to the information
studied to determine the composition of the sample probed. The setup of Raman spectroscopy is
depicted in Figure 3.
Raman spectroscopy has been used to discriminate strains of E. coli and other bacteria
types. Peak intensities and positions are commonly used to identify changes in a sample. Data
analysis schemes aiming to identify minute changes between bacterial strains have been
developed, including multivariate analysis (Germond et al., 2018; Sapers et al., 2019). The
literature indicates that Raman spectroscopy is capable of distinguishing changes in evolving
bacterial system (Martin & Pollock, 2010; Ren, Ji, Teng, & Zhang, 2017), suggesting that it should
be sensitive to detect chemical treatments applied to E. coli.
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Figure 3. Raman Spectroscopy Setup including the excitation laser (532nm), the objective for focusing and
collecting light, the notch filter to block elastically scattered light and the spectrometer to analyze the Raman signal.
The data is collected by a CCD detector in the spectrometer.

2.2.3 Fourier Transform Infrared Spectroscopy
FTIR also uses light-matter interaction to determine the chemistry of the sample. In this
case, the excitation is in the infrared range. The sample absorbs infrared energy that corresponds
to vibrational states of the chemical bonds in the material (Figure 4(a)). The spectra obtained can
be analyzed to determine the molecular composition and potentially the secondary structure of the
sample (Gallastegui et al., 2019). FTIR has been used to assess how E. coli and other gramnegative bacteria change when exposed to external stress (Corte et al., 2015). In a similar manner
as Raman spectroscopy, the position and intensity of the IR bands representing the functional
groups are used to determine the compositional changes in a sample (Gupta & Karthikeyan, 2016).
To characterize a sample in liquid, such as with bacteria, an attenuated total reflection (ATR)
configuration is commonly used. In ATR, the light passes through an IR transparent crystal
designed to create total internal reflection (Figure 4(b)). In the spectrometer used in this study, a
12

diamond layer was deposited on top of a ZnSe prism for protection. The incoming light is oriented
at an angle greater than the critical angle, resulting in the creation of evanescent waves that
illuminate the sample above the surface of the crystal with a depth of about 0.5-5 μm (Blum &
John, 2012). The energies absorbed to excite molecular vibrations do not get reflected, and result
in a “missing” band in the signal recorded by the detector.

(a)

(b)
Figure 4. FTIR Spectroscopy (a) and ATR configuration (b). FTIR spectroscopy consists in using mid-infrared
light to illuminate a sample and studying the absorbed energies by monitoring the signal with an IR detector. The
setup includes a Michelson interferometer as a mean to introduce an intensity modulation and interference pattern
that can be used to obtain the full IR spectrum in the 400-4000cm-1 range in a short collection time. The ATR
configuration allows for liquid measurement was using the concept of evanescent waves to probe the sample at the
interface of the ATR crystal. The total internal reflected wave contains the information of the sample.

For both Raman and FTIR spectroscopy, selection rules have been formulated to determine
whether an energy transition corresponding to a bond vibration is active or inactive. For this
reason, Raman and FTIR spectroscopy provide complementary information about the sample.
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Together, these three methods of characterization are expected to provide a holistic view
of how the treatments are affecting the bacteria to possibly identify markers specific to each
treatment mode of action.
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CHAPTER THREE: EXPERIMENTAL METHODS
3.1 Bacteria Growth
Culture and treatment of E. coli were performed in collaboration with Dr. Santra’s group.
The growth broth, incubation time for growth and the strain of E. coli were kept constant. One
method for the growth of E. coli consists of inoculating a single colony of E. coli in 10 mL of Luria
Bertani (LB) growth broth. The preparation was left overnight at 36˚C on a 150 rpm shaking table
(Maniprasad & Santra, 2012). Bacteria were studied in late log-phase or otherwise known as the
late exponential phase. Microbial growth in a culture sample or batch culture is usually modelled
using four different phases: the lag, lag, stationary and death phase. The exponential phase cells
growth is doubled, the growth rate is dependent on growth conditions such as nutrient
concentration and aeration (Prado Barragán, Figueroa, Rodríguez Durán, Aguilar González, &
Hennigs, 2016).
3.2 Bacteria Treatment
Antibiotics were obtained from Sigma Aldrich. Before evaluating the effects of the
treatments on the bacteria, the concentration and duration of the treatments had to be determined.
To address this, in collaboration with Dr. Santra’s team, we carried out Minimum Inhibitory
Concentration (MIC) assays.

3.2.1 Minimum Inhibitory Concentration
The Minimum Inhibitory Concentration (MIC) assay determines in vitro the concentration
necessary to significantly inhibit cell multiplication. This is usually done on a standardized
medium for 18 to 20 h from 34 to 37 °C. The MIC is an endpoint measurement and represents the
bacteriostatic response (Mouton et al., 2017). In this study, E. coli were treated in a 1:1 ratio with
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antibiotic. The MIC concentration ranges for colistin and streptomycin on E. coli were initially
estimated from the literature: colistin: >2 µg/ml, and streptomycin: 16 µg/ml (Iscla et al., 2014;
Sunde & Norstrom, 2005).

3.2.2 Bacterial Treatment
Once MIC were confirmed (colistin: 2.5 µg/ml, and streptomycin: 16 µg/ml) and E. coli
culture were grown, several steps were taken to combine the treatments with the bacteria and
prepare the sample for imaging.
For the control, a total of 1 ml of E. coli was used. For all other cases, the bacteria and
treatment were combined in a 1:1 ratio. After the treatment was added to the bacterial medium, the
cultures were incubated for varying time periods depending on the types of antibacterial being
used. A time study was performed for each antibiotic treatment. It was determined for colistin that
a 2-hour incubation period was optimal and a 4-hour incubation period for streptomycin at the
MIC was distinguishable from the control.

3.2.3 Sample preparation for imaging and spectroscopy
To prepare the E. coli solutions for infrared spectroscopy and nanoscale imaging, a washing
protocol was enacted. This included centrifuging the solution of E. coli for 5 minutes at 4000
relative centrifugal force, each time draining off the supernatant and adding approximately 1 ml
of double deionized water before resuspending the water and bacteria. The process was repeated
three times (Young, 2019). This washing protocol was validated for preliminary studies. Following
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washing, the bacteria were pipetted onto a substrate that is compatible with the measurements
(such as IR transparent substrate for infrared measurements) and allowed to dry in air.
3.3 Instrumental Setup
3.3.1 AFM Measurements
Silicon was used as the substrate since it offers a flat surface which prevents topographic
interference. Contact mode was used to acquire the height and deflection images of the sample
surface. A scan rate of 0.5-1.0 Hz was used to acquire images of 512 points x 512 points for a
region of 50 x 50 microns. A low force cantilever was used to prevent any damage to the bacteria.
Data analysis was performed with Gwyddion, ImageJ and Origin. The length and width
measurements were acquired using ImageJ; a total of 450 measurements were taken per sample.
The surface roughness measurement were taken using Gwyddion by acquiring the arithmetic mean
height Sa values for 180 measurements per sample.

3.3.2 Raman Spectroscopy Measurements
At the start of the project, we evaluated several substrates for this measurement (Figure 5).
We found that glass slides exhibit a signature interfering with the bacterial fingerprint. Hence, an
IR transparent substrate (Zinc Sulfide) was used to prevent interferences in the Raman spectral
range for E. coli.
A 532 nm laser was used as excitation source in the Raman confocal system (WITec 300
Alpha RA). Imaging was performed using a 100x objective. A region approximately 15x15 µm2
populated with E. coli cells was probed. The laser power ranged from 1.30 to 1.33 mW to ensure
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a good signal but to also prevent bacteria from burning. The 600 g/mm spectral grating was
selected. Inelastically scattered photons were collected by a CCD detector using an integration
time of 5 seconds (Germond et al., 2018). The spectra produced were corrected by cosmic rays
removal and background subtraction. Further analysis was performed using WITec Project,
Unscrambler, Origin and Fityk.

Figure 5. Raman Spectra of Substrates with Untreated E. coli samples (a) Untreated E. coli on calcium fluoride
substrate, (b) Untreated treated E. Coli on gold coated glass substrate (c) E. coli on silicon substrate.

3.3.3 FTIR Measurements
IR spectra were collected on a FTIR spectrometer (Perkin Elmer Spectrum One) covering
the 4000-400 𝑐𝑚−1 range and set to a resolution of 4 𝑐𝑚−1.
The FTIR was prepped by cleaning the crystal with isopropyl alcohol and Kim wipes. The
background of each sample was acquired by placing a few drops of water on the crystal and
acquiring the spectra. The sample spectra were then acquired. A total of 150 scan were acquired
for each sample and replicated three times with different drops of the solutions (Gupta &
Karthikeyan, 2016). The data was analyzed by Origin, Unscrambler and Fityk software.
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3.3.4 Statistical analysis
Analysis of variance (ANOVA) is frequently used statistical method of analysis. The focus
of ANOVA is the differences in group variances. This method asses the relative size of variances
among group means compared to the average variances with groups (Kim, 2014). ANOVA was
used in this study to determine the statistical significance of the results between treated and
untreated cells.
For infrared spectroscopy data, we deepened our analysis of the datasets with multivariate
analysis, which entails the statistical study of data where multiple measurements are made on each
experimental unit (Olkin & Sampson, 2001). It is based on the multidimensional observation and
analysis of multiple statistical outcome variable being analyzed at one time (Mengual-Macenlle,
Marcos, Golpe, & Gonzalez-Rivas, 2015).
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CHAPTER FOUR: EXPERIMENTAL RESULTS
The physical and chemical changes occurring in E. Coli due to various treatments were
investigated by nanoscale imaging and infrared spectroscopy, respectively. The physical changes
were assessed by comparing the morphology of the cells before and after treatment. The chemical
changes were studied by comparing Raman and IR bands of the bacteria fingerprint.

4.1 Morphology and roughness of the bacteria evaluated by AFM
The changes in length and width, as well as the surface roughness of E. Coli were
analyzed using AFM (Figure 6) to create a profile for the physical characteristics of the bacteria
both prior and post treatment.

Figure 6. AFM Images of untreated and treated E. coli. (a) Untreated E. coli 50x50 μm and 5x5 μm images, (b)
Colistin treated E. coli 50x50 μm and 5x5 μm images with 2-hour incubation period, and (c) Streptomycin treated E.
coli 50x50 μm and 5x5 μm images with 4-hour incubation period.
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Figure 7. Histograms of length measurement from AFM scans for untreated and treated E. coli. (a) Frequency
of length associated with untreated E. coli, (b) Frequency of length associated with colistin treated E. coli with 2
hours incubation period and (c) Frequency of length associated with streptomycin treated E. coli with 4 hours
incubation period.

Table 1. Summary of changes in the mean length of untreated and treated E. coli.

Treatment
Untreated
Colistin
Streptomycin

Mean Length (μm)
2.20 ± 0.49
2.06 ± 0.41
2.01 ± 0.47

Difference in mean (μm)
--------0.14
0.19

Length analysis was carried out from the AFM images collected. The histogram plots
(Figure 7) make it possible to determine changes in length of the bacteria as a result of the antibiotic
treatment. For the 450 bacteria that were analyzed, the untreated E. coli exhibited an average length
of 2.20 μm. This is in line with the known length property of E. coli, which is generally 1 to 2 μm
in length (El-Hajj & Newman, 2015). The measurements were extracted from 3 technical
replicates.
Following both the colistin and the streptomycin treatments, a slight reduction in length
could be observed, around 0.14 μm for colistin (corresponding to a 6% decrease) and 0.19 μm for
streptomycin (corresponding to an 8% decrease) (Table 1). This demonstrates that treatments
impact the size of E. Coli at the stage considered.
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Figure 8. Histogram of width measurements from AFM scans for untreated and treated E. coli. (a) Frequency
of width associated with untreated E. coli, (b) Frequency of width associated with colistin treated E. coli with 2
hours incubation period and (c) Frequency of width associated with streptomycin treated E. coli with 4 hours
incubation period.

Table 2. Summary of changes in the mean width of untreated and treated E. coli.

Treatment
Untreated
Colistin
Streptomycin

Mean Width (μm) Difference in mean (μm)
1.18 ± 0.14
-----1.15 ± 1.15
0.03
1.10 ± 0.21
0.08

Similar analysis was performed on the width of E. coli (Figure 8). An average width of
about 1.18 μm was found the untreated cells. This is on the larger end of the spectrum of reported
width of E. coli, which usually range between 0.5 to 1 μm (Nanninga, 1988). AFM is known to
provide some artifact in lateral measurements on samples such as bacteria, which could explain
the slightly high value. Nonetheless, we could use AFM to compare the width between untreated
and treated bacteria. With decreases of 0.08 μm for E. Coli following the streptomycin treatment
and of 0.03 μm for E. Coli following the colistin treatment, which represents a 2-6% variation, it
is difficult to confirm the impact of the treatment on the width of the cells (Table 2).
Nonetheless we note that overall streptomycin, the protein inhibiting treatment, seems to
have a greater effect on cell sizes than colistin, the cell wall degrading treatment.
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Figure 9. Histogram of surface roughness from AFM scans for untreated and treated E. coli. (a) Frequency of
surface roughness associated with untreated E. coli, (b) Frequency of surface roughness associated with colistin
treated E. coli with 2 hours incubation period and (c) Frequency of surface roughness associated with streptomycin
treated E. coli with 4 hours incubation period.

Table 3. Summary of changes in the mean width of untreated and treated E. coli.

Treatment

Mean Roughness (nm)

Untreated
Colistin
Streptomycin

85.53 ± 25.39
43.96 ± 22.26
40.43 ± 16.39

Difference in mean
(nm)
-----41.57
45.10

Given that AFM offers finer details due to its spatial resolution beyond 100 nm, we
investigated the surface roughness of the cells. Bacterial surface roughness is known to play a
major role in their attachment and removal ability (H. Wang, Feng, Liang, Luo, & Malyarchuk,
2009). The histograms in Figure 9 show the evolution of surface roughness because of antibiotic
treatments. A total of 180 measurements were taken per sample treatment using the Gwyddion
software. A mask was added to the region in evaluation and the statistical properties of the masked
region were analyzed using the software. The surface roughness measurements were taken using
the arithmetic mean height values, Sa. As summarized in Table 3, the untreated E. coli had an
average surface roughness of 85.53 nm. Streptomycin led to the greatest reduction in surface
roughness with a decrease of 45.10 nm from that of the untreated (~53% decrease). Colistin also
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showed a significant decrease in surface roughness, of about 41.57 nm (~48%). This could be an
indication that with treatment the bacteria are less capable of attachment due to its reduction in
surface roughness.
The study of the physical traits of E. Coli suggests that both mode of actions affect the
size and surface roughness of the cells, although streptomycin, the protein inhibiting treatment,
seems to have a slightly higher effect (Figure 10). It showed a greater reduction in both width,
length and surface roughness measurements. Next we detail our evaluation of the data using
Analysis of variance (ANOVA) to determine statistical significance of the differences observed
(Table 4).

Figure 10. Box Plots of length, width and surface roughness distributions for untreated and treated E. coli.
For all samples the box represents the 25th to 75th percentile, whiskers indicate the standard deviation and the middle
square shows the mean. (a) Length distribution of treated and untreated E. coli, (b) Width distribution of treated and
untreated E. coli (c) Surface roughness distribution of treated and untreated E. coli.

Table 4. Statistical significance of p-tests with treated and untreated samples for (a) length, (b) width, and (c)
surface roughness. For all sample 1 represents statistical significance and 0 represents no statistical significance.
(a)

Sample
Relationship
Colistin,
Untreated
Streptomycin,
Untreated
Streptomycin,
Colistin
Colistin,
Untreated
Streptomycin,
Untreated
Streptomycin,
Colistin

(b)

ptest
0.05

Sig.*

0.05

1

0.05

0

0.01

1

0.01

1

0.01

0

1

(a)

Sample
Relationship
Colistin,
Untreated
Streptomycin,
Untreated
Streptomycin,
Colistin
Colistin,
Untreated
Streptomycin,
Untreated
Streptomycin,
Colistin

ptest
0.05

Sig.*

0.05

1

0.05

1

0.01

1

0.01

1

0.01

0
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1

Sample
Relationship
Colistin,
Untreated
Streptomycin,
Untreated
Streptomycin,
Colistin
Colistin,
Untreated
Streptomycin,
Untreated
Streptomycin,
Colistin

ptest
0.05

Sig.*

0.05

1

0.05

0

0.01

1

0.01

1

0.01

0

1

Colistin,
0.001 1
Untreated
Streptomycin, 0.001 1
Untreated
Streptomycin, 0.001 0
Colistin

Colistin,
0.001 1
Untreated
Streptomycin, 0.001 1
Untreated
Streptomycin, 0.001 0
Colistin

Colistin,
0.001 1
Untreated
Streptomycin, 0.001 1
Untreated
Streptomycin, 0.001 0
Colistin

Sig.* = Significance
In biology, natural variations are responsible for changes in properties within a large
ensemble of the same sample group. For instance, here, within the group on untreated bacteria, a
range of length, width and surface areas could be observed (Figures 6-10 and Tables 1-4). To
determine whether the behavior of one sample group is significantly different from that of a second
sample group, statistical models have been implemented, such as ANOVA – developed by R.
Fisher (Fisher, 1919). One-way ANOVA with the combination of the post hoc Tukey test (Tukey’s
Honestly Significant Difference (HSD)) was conducted on the samples. Conducting a post hoc
Tukey test with one-way ANOVA can test the differences among sample means for significance.
The post hoc Tukey test has a better probability of controlling Type I errors; this is an incorrect
rejection of true of the null hypothesis ("Encyclopedia of Research Design," 2010; Kim, 2015).
Table 4 serves as an identifier for the statistical significance of each physical quantity of E. coli
between each treatment and the untreated sample groups and between colistin treated and
streptomycin treated groups. The differences between untreated and treated samples were found
to be statistically significant at all three p-test, 0.05, 0,01 and 0.001. However, no statistical
significance was found between the sample groups treated with colistin and streptomycin. Thus,
length alone cannot be used as a physical marker of the mode of action.
Differences in width between treated and untreated groups were significant at all levels,
however the width values to differentiate the two modes of actions were not statistically significant
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according to p-tests 0.01 and 0.001. We note that significance existed at p-test 0.05. Thus width
measurements alone cannot be used as a reliable physical marker of the mode of action. Surface
roughness of E. coli resulting from antibiotics treatments were also statistically significant when
compared to the untreated sample group, but not when comparing the two treated groups. Thus
surface roughness measurements alone cannot be used as a reliable physical marker of the mode
of action.
Due to the lack in specificity of this measurements to differentiate the control groups, we
investigated the chemical signatures of the bacteria.
4.2 Composition of the bacteria investigated by infrared spectroscopy
The Raman and IR spectra were collected as described in Chapter 3. Interpretation of the
spectra is discussed here, first on the as-collected spectra and later refined using peak
deconvolution.

4.2.1. Raman and IR signatures of E. Coli
4.2.1.1 Raman Spectra of E. Coli
Raman spectra of the untreated E. Coli (Figure 11) were analyzed by studying previous reports in
the literature (Harz, Rösch, & Popp, 2009; Rösch et al., 2005; Wei, Li, & Zhao, 2018). Water
signal in Raman spectroscopy is generally not an issue do to the band above 3200 cm-1, which
does not overlap with the fingerprint of bacteria in the 1000-1700 cm-1 and the region with strong
hydrocarbon groups (CH, CH2, CH3) in the 2800-3000 cm-1 range. The fingerprint of untreated
bacteria revealed several bands previously reported in the literature, the strongest one being at
~2935 cm-1, which corresponds to a C-H stretching. The features are in good agreement with a
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report by Harz et al. (Harz et al., 2009), which also used a 532 nm laser excitation to study
bacterial cells Staphylo-coccus epidermidis ATCC 35984. In their study, the Raman signature of
important building blocks of the bacteria were presented, and showed that DNA,
polysaccharides, lipids and proteins all exhibit a strong signal in the 2800-3000 cm-1 region. The
peak with maximum position at ~2935 cm-1 seems to be best aligned with the signal of proteins,
while other side bands observed in our data at 2971 cm-1 and 2885 cm-1 would correspond to
DNA and polysaccharides and/or lipids, respectively. Proteins were found to have several bands
related to amide vibrations, including amide I (~1668 cm-1) and amide III (1253 cm-1) (Harz et
al., 2009). The amide II band was not directly observed in our spectra. A small bands at ~ 1570
cm-1 could be representative of DNA while the C=O vibration of lipids is expected to lay ~ 1750
cm-1.

Figure 11. Raman spectra of untreated E. coli. (a)Untreated bacteria for spectral range of 1000-3500 cm-1 and (b)
Untreated bacteria for spectral range of 1000-1700 cm-1.

Table 5. Summary of the Raman modes detected for untreated E. coli.

Wavenumber (cm-1)
1013

Bond vibration
Out of phase C-C-O
stretch
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Reference
(Talari, Movasaghi,
Rehman, & Rehman,
2015)

1107
1239
1314
1458
1556
1668
2886
2930
2971
2800-3000

C-O-C in carbohydrates
C-C-O out of phase
Amide III, lipids
CH deformation
CH2 scissoring
Amide II
Amide I
CH2 stretch
CH2 asymetic strecth
asymmetric Stretching of
Methoxy(4)
CH, CH2, CH3

(Wei et al., 2018)
(Germond et al., 2018)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)

After treatments with the antibiotics (Figure 12), the bacteria exhibited some changes in
fingerprint. Small changes in the bands at ~ 1013 cm-1 and ~1556 cm-1 were observed after the
treatments suggesting a change in E. coli’s composition.

Figure 12. Raman spectra of untreated and treated E. coli. (a) Untreated and treated bacteria with no incubation
with formulation of treatment for spectral range of 1000-3500 cm-1 and (b) Untreated and treated bacteria with
formulation of treatment for spectral range of 1000-1700 cm-1

Table 6. Bands of untreated and treated E. coli. From Raman spectra for both the 1000-1700 cm-1 and 1000-3500
cm-1 range, where X represents that the band was unchanged.

28

1107

Bands of
bacteria
treated with
colistin
(cm-1)
X

1239

X

X

C-O-C in
carbohydrates
C-C-O out of phase
Amide III

1314

X

1330

1330; Phospholipids

1458

1454

1454

CH2 deformation

1556

Absent

Absent

Amide II

1668

1656

X

1656; Amide I

Bands of
untreated
bacteria
(cm-1)

Bands of bacteria
treated with
streptomycin
(cm-1)
X

Functional group

Reference

(Talari et al., 2015)

(Germond et al.,
2018; Talari et al.,
2015)
(Germond et al.,
2018; Talari et al.,
2015)
(Germond et al.,
2018; Talari et al.,
2015)
(Germond et al.,
2018; Talari et al.,
2015)
(Talari et al., 2015)

CH2 defomation, potentially associated with phospholipid and collagen (Talari et al.,
2015), were identified based on the shift of the 1458 cm-1 band. The amide I compound was still
present after the colistin treatment however, the wavenumber shifted from 1668 cm-1 to 1656 cm1

.
Streptomycin had a similar spectral change to colistin, as the bands at ~1013 and 1556

cm-1 (amide II) were both affected. Similar shift of the CH2 defomation was observed. The main
difference was the shift of the 1314 cm-1 to 1330 cm-1 , indicative of a change in phospholipids.
Phospholipids play serveral roles in bacteria, one major role being to establish the permeability
barrier of the bacterial cell (Cronan, 2003).
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4.2.1.2 IR Spectra of E. coli

IR spectra are complementary to Raman spectra. In our study the two methods did not
probe the same volume. FTIR measurements correspond probing several bacteria whereas
Raman probes one cell at a time.

Figure 13. FTIR spectra of untreated and treated E. coli. (a)Untreated bacteria with no incubation with
formulation of treatment for spectral range of 1000-1700 cm-1 and (b) Untreated and treated bacteria with
formulation of treatment for spectral range of 1000-1750 cm-1

Table 7. Summary of the IR modes detected for untreated E. coli.

Wavenumber (cm-1)
1052
1223
1333
1422
1471
1576
1631
1653

Functional group
P=O
C-O str
NO or CO
CH2 deformation
CH2 bending of lipid
Amide II
Amide I or II
Amide I

The spectrum (Figure 13(a)) reveals the IR active compounds of untreated E. coli. There appears
to be signals from varous bonds, including P=O (Movasaghi, Rehman, & ur Rehman, 2008), as
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well as bands related to lysaccharides and amides, similar to Raman spectra. Bacterial
polysaccharides are usually associated with bacterial cell wall and membrane and amide stutures
help classify the state of proteins of the bacteria (Misra, Sharma, & Srivastava, 2015). Additonal
stutures such as the C=N and CH2 bending of lipids were present. The C-H stretching vibration
can sometimes be used to gain information on the state of the freedom of motion and fatty acyl
order (Guler, Gartner, Ziegler, & Mantele, 2016). A summary of the bands is provided in Table
8.

Table 8. Bands of untreated and treated E. coli. X represents the same band as the untreated.

Bands of
untreated
bacteria
(cm-1)
1052
1223
1333
1422

Bands of
bacteria treated
with colistin
(cm-1)
1043
1282
Absent
Absent

Bands of bacteria
treated with
streptomycin
(cm-1)
1054
1218
Absent
Absent

1471

1448

1469

1576
1631
1653

1549
Absent
X

1548
Absent
1641

Functional group
P=O
Amide III
----CH3 bending of
proteins
Amide II
--Amide I

Next we compared the reference spectrum of the untreated bacteria (Figure 13) to the
fingerprint recorded for the treated samples (Figure 13(b)). In presence of the protein inhibiting
treatments amide I shifted from an alpha helix structure at 1653-1657 cm-1 to a lower
wavenumber amide I structure at 1641 cm-1(Movasaghi et al., 2008). In presence of colistin, the
cell wall degrading treatment, the amide I band region did not change. However, a significant
shift of the band at1222 cm-1 was observed in the case of colistin treatment, with a shift to 1282
cm-1. This was not observed for streptomycin. The 1576 cm-1 band shifted for both treatments.
31

4.2.2. Peak deconvolution
To refine our study of the different bands, we also experimented with spectral peak
deconvolution. This approach allows the decomposing of broad peaks into several sub-bands
that overlap, which can provide information about otherwise hidden peaks. Fityk peak
deconvolution software was used to deconvolute all spectra. We note here that peak
deconvolution is a complex process that can provide varying outcomes, thus the analysis
presented here should not be considered as final.
Overall, this step revealed that the antibiotic treatments with different modes of action
may offer distinct markers related to the mode of action.

Figure 14. Raman peak deconvolution for untreated and treated E. coli. (a)Untreated bacteria with no
incubation with formulation of treatment, (b) Colistin treated bacteria with 2 hours incubation period formulation of
treatment, and (c) Streptomycin treated bacteria with 4 hours incubation period formulation of treatment.
Table 9. Summary of the Raman Peak Deconvolution. (a) Relative Raman shift of comparison of compound in
untreated with those of treatment, (b) Potential Raman shift of bands (not present in untreated) that occur due to 2
hours incubated colistin treatment, and (c) Potential Raman shift of bands (not present in untreated) that occur due to
4 hours incubated streptomycin treatment.
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(a)

Compound
Amide I
Tyrosine
Cytosine
Fatty Acid
C=C
Tryptophan
Amide III
Carbohydrate
Phospholipid

Untreated
1668
1615
1510
1440
1417
1365
1258
1153
1078

Colistin
1697
----1546
1224
---

Streptomycin
1670
1548
-1233
-1548
-1063
--

References
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)

(b)

Compound
Amide I
Guanine
Deoxyribose
C-H Rocking
Amide III
Lipid
Amide I
C-C
Glucose
Phenylalanine of Collagen
Tryptophan

Colistin
1663, 1640
1570
1455
1389
1318
1255
1172
1100
1071
1030
1011

References
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)

Streptomycin
1647
1582
1457
1323
1233
1095
1063

References
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)
(Talari et al., 2015)

(c)

Compound
Amide I
Phenylalanine
Deoxyribose
Guanine
Fatty Acid
Lipid
C-C

Our tentative deconvolution revealed various shifts specific each treatment (Figure 14). In
addition, several peaks that were not present in the untreated sample seemed to appear after
treatment (Table 9). This suggests that Raman spectroscopy when paired with peak deconvolution
can serve as a method to distinguish the chemical signature associated with treatments that
correspond to the mode of action of the treatment.
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Figure 15. FTIR peak deconvolution for untreated and treated E. coli. (a)Untreated bacteria with no incubation
with formulation of treatment, (b) Colistin treated bacteria with 2 hours incubation period formulation of treatment,
and (c) Streptomycin treated bacteria with 4 hours incubation period formulation of treatment.

Table 10. Wavenumber shift for FTIR peak deconvolution. (a) FTIR wavenumber comparison of compound in
untreated with those of treatment, (b) Potential assignment of FTIR bands (not present in untreated) that occur due to
2 hours incubated colistin treatment, and (c) Potential assignment of FTIR bands (not present in untreated) that
occur due to 4 hours incubated streptomycin treatment.
(a)

Compound
Amide I

Untreated
1652

Colistin
1652

Streptomycin
1634

Nucleic Acid

1619

Amide II

1536

Phospholipid

1469

--

--

Collagen

1364

--

--

C-N Thymine

1328

--

--

N-H Thymine

1290

--

--

Amide III

1230

--

1282

Polysaccharide

1162

--

1125

RNA

1117

1117

--

Phosphate II

1087

1092

--

--

--

1550

1543
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References
(Movasaghi et
al., 2008)
(Movasaghi et
al., 2008)
(Faghihzadeh,
Anaya,
Schifman, &
OyanedelCraver, 2016)
(Movasaghi et
al., 2008)
(Movasaghi et
al., 2008)
(Movasaghi et
al., 2008)
(Movasaghi et
al., 2008)
(Movasaghi et
al., 2008)
(Movasaghi et
al., 2008)
(Movasaghi et
al., 2008)
(Movasaghi et
al., 2008)

Carbohydrate

1053

Glycogen

1022

--

--

1045

--

(Movasaghi et
al., 2008)
(Movasaghi et
al., 2008)

(b)

Compound
C=O

Colistin
1712

Amide II

1517

Lipids

1444

Deformation C-H, N-H

1416

Deformation C-H, N-H

1355

Polysaccharide

1334

N-H Thymine

1288

Collagen

1224

Deoxyribose

1118

Tyrosine

1162

References
(Movasaghi et al.,
2008)
(Movasaghi et al.,
2008)
(Movasaghi et al.,
2008)
(Movasaghi et al.,
2008)
(Movasaghi et al.,
2008)
(Movasaghi et al.,
2008)
(Movasaghi et al.,
2008)
(Movasaghi et al.,
2008)
(Movasaghi et al.,
2008)
(Movasaghi et al.,
2008)

(c)

Compound
C=N Adenine
Amide II
Polysaccharide
Deformation
C-H, N-H
Deformation
C-H, N-H
Amide III
Phosphate I
Phosphate I
CH2
Polysaccharide
Deoxyribose
Polysaccharide

Streptomycin
1574
1517
1434
1412

References
(Movasaghi et al., 2008)
(Movasaghi et al., 2008)
(Movasaghi et al., 2008)
(Movasaghi et al., 2008)

1360

(Movasaghi et al., 2008)

1319
1235
1212
1183
1110
1056
1018

(Movasaghi et al., 2008)
(Movasaghi et al., 2008)
(Movasaghi et al., 2008)
(Movasaghi et al., 2008)
(Movasaghi et al., 2008)
(Movasaghi et al., 2008)
(Movasaghi et al., 2008)

The FTIR peak deconvolution of treated and untreated E. coli confirmed that the
chemistry of the bacteria changed (Figure 15). The amide I, II and III bands present in the
untreated sample shifted in the treated samples indicating changes in the membranes (Table 10).
When the treated samples were compared, the deformation of C-H and N-H are present in both
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samples although they were not the same in untreated sample. It is also essential to note that
several polysaccharide bands absent in the untreated were found in the streptomycin treated
bacteria.
Both the peak deconvolution conducted from Raman and FTIR spectroscopy show
changes in the bacteria fingerprint due to treatments. This is distinguished due to the shape of the
spectra and the various difference in the compounds present in the untreated and treated samples.

4.2.3. Principal Component Analysis
Principal component analysis (PCA) is a multivariate technique that analyzes data by
several inter-correlated quantitative dependent variables. It makes it possible to identify
variances in complex datasets by representing it in a set of new orthogonal variables, which are
the principal components. For visualization, each spectrum is plotted as point in a map using
principal components as x- and y- axes (Abdi & Williams, 2010). PCA reduces the
dimensionality of large datasets, which increases interpretability and minimizes the information
loss, solving eigenvector problem [64]. It creates new uncorrelated variables that successively
maximize variance. (Jolliffe & Cadima, 2016)
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Figure 16. Principal Component Analysis for untreated and treated E. coli for Raman scans. (a) Comparison
of loadings for principal component loadings 1 and 2 (b) Distribution of untreated and treated bacteria with respect
to Principal Component 1 and 2

PCA of the Raman datasets of untreated and antibiotic-treated samples determined a PC
1 (72%) axis and PC 2 (12%) (Figure 16). The data suggests that the untreated sample had
significant variations in the regions probed. The treated samples revealed no overlap with the
untreated samples. The cluster belonging to the two treatments overlapped with each other,
which suggests that while the samples are different from the untreated that both treatments share
similarities for a few data points.
PCA allows for the difference in the various principal component loadings and their
corresponding wave numbers to be identified by representing the loadings as a function of
wavenumber. The data suggest that the main distinction between the PC1 and PC2 here in the
presence/absence of the bands in the 2700-3300 cm-1 region. These bands are mostly associated
with C-H stretching (Talari et al., 2015).
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Figure 17. Principal Component Analysis for untreated and treated E. coli for FTIR scans.
(a) Comparison of loadings for principal component loadings 1&2 (b) Distribution of untreated
and treated bacteria with respect to Principal Component 1 and 2

For the PCA analysis of the FTIR spectra (Figure 17), the data points from the three
sample groups did not clearly separate despite the changes observed when comparing the
individual spectra. This suggests that additional refinement of the data analysis should be carried
out to confirm our observations.
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Chapter 5: Conclusion
Our study considered nanoscale image and infrared spectroscopy as potential platforms
capable of differentiating physical and chemical traits in bacteria being inhibiting via different
modes of action. Our hypothesis was formulated on the premise of several reports in the literature
indicating that both methods are sensitive the bacterial evolution under various stresses.
The data gathered indicates that even though significant differences arise upon treatments
of E. coli, the distinction of the morphological changes with respect to the mode of action of the
treatment was not straightforward. The simple comparison of length, width and surface roughness
was not sufficient to clearly establish a distinction that could be used for mode of action
identification.
Raman spectra seemed to provide a better differentiation of the treated cells, although the
identification of the bands is complex and will require additional work. The present understanding
of the data would suggest changes in the amide I, II and III bands of the cells. The changes observed
in the FTIR spectra could not be confirmed with multivariate analysis, which should be considered
further to pinpoint the origin of this issue.
Overall the data tends to agree with our initial hypothesis although a definite identification
of the changes in bacteria due to a specific mode of action could not be achieved in the scope of
this study. It is likely that with more work, chemical and physical indicators could serve as an
establishment for indication of the mode of action of treatments.
The significance of this work is to be considered in the context of emerging multidrug
resistance in bacteria. As the developments of new formulations for combating bacterial infections
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is becoming crucial, various nanoparticles engineered to provide tailored mode(s) of action and
targeted delivery are being developed (Yin et al., 2014). For instance, the antibacterial activity of
zinc oxide (ZnO) NPs has received some interest as an alternative to multidrug resistance for
several strains of bacteria (Husen & Siddiqi, 2014; Tiwari et al., 2018). Metal oxides have been
shown to diffuse into the bacterial cell and release metal ions, leading to cell death. Zn2+ ions can
attach to the biomolecules in the bacteria cell via electrostatic forces, which further contributes to
antibacterial activity (Brayner et al., 2006). However, the mode of action of these new compounds
is difficult to assess. Some studies lean towards membrane disruption as the main effect of ZnO
NPs on bacteria such as Campylobacter jejuni (Xie, He, Irwin, Jin, & Shi, 2011). Other studies
have suggested that ZnO NPs may induce intercellular reactive oxygen species (ROS) such as
hydrogen peroxide, which act as an oxidizing agent to harm the bacterial cells – this would mean
an ROS mode of action (Jones, Ray, Ranjit, & Manna, 2008). Further research carried out on ZnONP and E. coli shows that ZnO-NPs can adhere to bacterial cell walls. This can lead to the
bacteria’s outer membrane being ruptured, the intracellular material leaking out, leading to cell
death (Wahab, Mishra, Yun, Kim, & Shin, 2010). Despite these independent studies, the mode of
action of ZnO NPs remains unclear.
The approach considered in this work, if developed further to discriminate the physics and
chemical traits from bacteria undergoing different treatments, could provide support to accelerate
the development of new treatments for bacterial diseases in medicine and in agriculture.

40

REFERENCES
Abdi, H., & Williams, L. J. (2010). Principal component analysis. WIREs Computational Statistics, 2(4),
433-459. doi:10.1002/wics.101
Aćimović, S. G., Zeng, Q., McGhee, G. C., Sundin, G. W., & Wise, J. C. (2015). Control of fire blight
(Erwinia amylovora) on apple trees with trunk-injected plant resistance inducers and antibiotics
and assessment of induction of pathogenesis-related protein genes. Frontiers in Plant Science,
6(16). doi:10.3389/fpls.2015.00016
Aduse-Opoku, J., Slaney, J. M., Hashim, A., Gallagher, A., Gallagher, R. P., Rangarajan, M., . . . Curtis, M.
A. (2006). Identification and characterization of the capsular polysaccharide (K-antigen) locus of
Porphyromonas gingivalis. Infect Immun, 74(1), 449-460. doi:10.1128/iai.74.1.449-460.2006
Alavi, M., & Rai, M. (2019). Recent advances in antibacterial applications of metal nanoparticles (MNPs)
and metal nanocomposites (MNCs) against multidrug-resistant (MDR) bacteria. Expert Review of
Anti-Infective Therapy, 17(6), 419-428. doi:10.1080/14787210.2019.1614914
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., . . . Baloch, Z. (2018).
Antibiotic resistance: a rundown of a global crisis. Infection and Drug Resistance, 11, 1645-1658.
doi:10.2147/idr.S173867
Baptista, P. V., McCusker, M. P., Carvalho, A., Ferreira, D. A., Mohan, N. M., Martins, M., & Fernandes, A.
R. (2018a). Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans". Front
Microbiol, 9, 1441. doi:10.3389/fmicb.2018.01441
Baptista, P. V., McCusker, M. P., Carvalho, A., Ferreira, D. A., Mohan, N. M., Martins, M., & Fernandes, A.
R. (2018b). Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans".
Frontiers in Microbiology, 9, 26. doi:10.3389/fmicb.2018.01441
Barak, I., & Muchova, K. (2013). The role of lipid domains in bacterial cell processes. Int J Mol Sci, 14(2),
4050-4065. doi:10.3390/ijms14024050
Blount, Z. D. (2015). The unexhausted potential of E. coli. Elife, 4. doi:10.7554/eLife.05826
Blum, M. M., & John, H. (2012). Historical perspective and modern applications of attenuated total
reflectance–Fourier transform infrared spectroscopy (ATR‐FTIR). Drug testing and analysis, 4(34), 298-302.
Brayner, R., Ferrari-Iliou, R., Brivois, N., Djediat, S., Benedetti, M. F., & Fievet, F. (2006). Toxicological
impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal
medium. Nano Lett, 6(4), 866-870. doi:10.1021/nl052326h
Chang, Q., Wang, W., Regev-Yochay, G., Lipsitch, M., & Hanage, W. P. (2015). Antibiotics in agriculture
and the risk to human health: how worried should we be? Evol Appl, 8(3), 240-247.
doi:10.1111/eva.12185
Cheng, J., Wang, Y. D., Pan, Y. T., Li, X. L., Hu, J., & Lu, J. H. (2019). Single-molecule nanomechanical
spectroscopy shows calcium ions contribute to chain association and structural flexibility of
blood clotting factor VIII. Biochemical and Biophysical Research Communications, 513(4), 857861. doi:10.1016/j.bbrc.2019.04.068
Chisanga, M., Muhamadali, H., Ellis, D. I., & Goodacre, R. (2019). Enhancing Disease Diagnosis:
Biomedical Applications of Surface-Enhanced Raman Scattering. Applied Sciences-Basel, 9(6).
doi:10.3390/app9061163

41

Corte, L., Tiecco, M., Roscini, L., De Vincenzi, S., Colabella, C., Germani, R., . . . Cardinali, G. (2015). FTIR
Metabolomic Fingerprint Reveals Different Modes of Action Exerted by Structural Variants of NAlkyltropinium Bromide Surfactants on Escherichia coli and Listeria innocua Cells. Plos One,
10(1), 15. doi:10.1371/journal.pone.0115275
Cronan, J. E. (2003). Bacterial membrane lipids: where do we stand? Annu Rev Microbiol, 57, 203-224.
doi:10.1146/annurev.micro.57.030502.090851
De Kruijff, B., Killian, J. A., Rietveld, A. G., & Kusters, R. (1997). Chapter 13 Phospholipid Structure and
Escherichia Coli Membranes. In R. M. Epand (Ed.), Current Topics in Membranes (Vol. 44, pp.
477-515): Academic Press.
Delcour, A. H. (2009). Outer membrane permeability and antibiotic resistance. Biochimica et biophysica
acta, 1794(5), 808-816. doi:10.1016/j.bbapap.2008.11.005
Doi, Y., Bonomo, R. A., Hooper, D. C., Kaye, K. S., Johnson, J. R., Clancy, C. J., . . . a, f. t. G.-N. C. o. t. A. R.
L. G. (2017). Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and
Future Directions of the Antibacterial Resistance Leadership Group. Clinical Infectious Diseases,
64(suppl_1), S30-S35. doi:10.1093/cid/ciw829
Dufrene, Y. F. (2014). Atomic Force Microscopy in Microbiology: New Structural and Functional Insights
into the Microbial Cell Surface. Mbio, 5(4). doi:10.1128/mBio.01363-14
Dupuy, F. G., Pagano, I., Andenoro, K., Peralta, M. F., Elhady, Y., Heinrich, F., & Tristram-Nagle, S. (2018).
Selective Interaction of Colistin with Lipid Model Membranes. Biophysical Journal, 114(4), 919928. doi:https://doi.org/10.1016/j.bpj.2017.12.027
El-Hajj, Z. W., & Newman, E. B. (2015). An <span class="named-content genus-species" id="namedcontent-1">Escherichia coli</span> Mutant That Makes Exceptionally Long Cells. Journal of
Bacteriology, 197(8), 1507-1514. doi:10.1128/jb.00046-15
Encyclopedia of Research Design. (2010). doi:10.4135/9781412961288
Faghihzadeh, F., Anaya, N. M., Schifman, L. A., & Oyanedel-Craver, V. (2016). Fourier transform infrared
spectroscopy to assess molecular-level changes in microorganisms exposed to nanoparticles.
Nanotechnology for Environmental Engineering, 1(1), 1. doi:10.1007/s41204-016-0001-8
Fair, R. J., & Tor, Y. (2014). Antibiotics and bacterial resistance in the 21st century. Perspect Medicin
Chem, 6, 25-64. doi:10.4137/pmc.S14459
Fisher, R. A. (1919). XV.—The correlation between relatives on the supposition of Mendelian
inheritance. Earth and Environmental Science Transactions of the Royal Society of Edinburgh,
52(2), 399-433.
Friedman, N. D., Temkin, E., & Carmeli, Y. (2016). The negative impact of antibiotic resistance. Clinical
Microbiology and Infection, 22(5), 416-422. doi:https://doi.org/10.1016/j.cmi.2015.12.002
Gallastegui, A., Spesia, M. B., dell'Erba, I. E., Chesta, C. A., Previtali, C. M., Palacios, R. E., & Gomez, M. L.
(2019). Controlled release of antibiotics from photopolymerized hydrogels: Kinetics and
microbiological studies. Materials Science & Engineering C-Materials for Biological Applications,
102, 896-905. doi:10.1016/j.msec.2019.04.027
Germond, A., Ichimura, T., Horinouchi, T., Fujita, H., Furusawa, C., & Watanabe, T. M. (2018). Raman
spectral signature reflects transcriptomic features of antibiotic resistance in Escherichia coli.
Communications Biology, 1. doi:10.1038/s42003-018-0093-8
Grayson, M. L., Cosgrove, S. E., Crowe, S., Hope, W., McCarthy, J. S., Mills, J., . . . Paterson, D. L. (2017).
Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and
Antiviral Drugs, -Three Volume Set: CRC Press.

42

Guler, G., Gartner, R. M., Ziegler, C., & Mantele, W. (2016). Lipid-Protein Interactions in the Regulated
Betaine Symporter BetP Probed by Infrared Spectroscopy. J Biol Chem, 291(9), 4295-4307.
doi:10.1074/jbc.M114.621979
Gupta, A. D., & Karthikeyan, S. (2016). Individual and combined toxic effect of nickel and chromium on
biochemical constituents in E. coli using FTIR spectroscopy and Principle component analysis.
Ecotoxicology and Environmental Safety, 130, 289-294.
doi:https://doi.org/10.1016/j.ecoenv.2016.04.025
Gurunathan, S. (2019). Rapid biological synthesis of silver nanoparticles and their enhanced antibacterial
effects against Escherichia fergusonii and Streptococcus mutans. Arabian Journal of Chemistry,
12(2), 168-180. doi:10.1016/j.arabjc.2014.11.014
Harz, M., Rösch, P., & Popp, J. (2009). Vibrational spectroscopy—A powerful tool for the rapid
identification of microbial cells at the single-cell level. Cytometry Part A, 75A(2), 104-113.
doi:10.1002/cyto.a.20682
Hemeg, H. A. (2017). Nanomaterials for alternative antibacterial therapy. Int J Nanomedicine, 12, 82118225. doi:10.2147/ijn.S132163
Hinchliffe, P., Yang, Q. E., Portal, E., Young, T., Li, H., Tooke, C. L., . . . Spencer, J. (2017). Insights into the
Mechanistic Basis of Plasmid-Mediated Colistin Resistance from Crystal Structures of the
Catalytic Domain of MCR-1. Scientific Reports, 7, 10. doi:10.1038/srep39392
Husen, A., & Siddiqi, K. S. (2014). Phytosynthesis of nanoparticles: concept, controversy and application.
Nanoscale Research Letters, 9. doi:10.1186/1556-276x-9-229
Ibrahim, M. K., Mattar, Z. A., Abdel-Khalek, H. H., & Azzam, Y. M. (2017). Evaluation of antibacterial
efficacy of anise wastes against some multidrug resistant bacterial isolates. Journal of Radiation
Research and Applied Sciences, 10(1), 34-43. doi:https://doi.org/10.1016/j.jrras.2016.11.002
Iscla, I., Wray, R., Wei, S. G., Posner, B., & Blount, P. (2014). Streptomycin potency is dependent on MscL
channel expression. Nature Communications, 5, 7. doi:10.1038/ncomms5891
Jann, K., & Jann, B. (1987). Polysaccharide antigens of Escherichia coli. Rev Infect Dis, 9 Suppl 5, S517526. doi:10.1093/clinids/9.supplement_5.s517
Jolliffe, I. T., & Cadima, J. (2016). Principal component analysis: a review and recent developments.
Philos Trans A Math Phys Eng Sci, 374(2065), 20150202. doi:10.1098/rsta.2015.0202
Jones, N., Ray, B., Ranjit, K. T., & Manna, A. C. (2008). Antibacterial activity of ZnO nanoparticle
suspensions on a broad spectrum of microorganisms. FEMS Microbiol Lett, 279(1), 71-76.
doi:10.1111/j.1574-6968.2007.01012.x
Kim, H. Y. (2014). Analysis of variance (ANOVA) comparing means of more than two groups. Restor Dent
Endod, 39(1), 74-77. doi:10.5395/rde.2014.39.1.74
Kim, H. Y. (2015). Statistical notes for clinical researchers: Type I and type II errors in statistical decision.
Restor Dent Endod, 40(3), 249-252. doi:10.5395/rde.2015.40.3.249
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010). How antibiotics kill bacteria: from targets to
networks. Nat Rev Microbiol, 8(6), 423-435. doi:10.1038/nrmicro2333
Li, M., Gan, C. Y., Shao, W. X., Yu, C., Wang, X. G., & Chen, Y. (2016). Effects of membrane lipid
composition and antibacterial drugs on the rigidity of Escherichia coli: Different contributions of
various bacterial substructures. Scanning, 38(1), 70-79. doi:10.1002/sca.21243
Liu, X., & Ferenci, T. (1998). Regulation of Porin-Mediated Outer Membrane Permeability by Nutrient
Limitation in <em>Escherichia coli</em>. Journal of Bacteriology, 180(15), 3917-3922. Retrieved
from https://jb.asm.org/content/jb/180/15/3917.full.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC107376/pdf/jb003917.pdf

43

Luirink, J., Yu, Z., Wagner, S., & de Gier, J.-W. (2012). Biogenesis of inner membrane proteins in
Escherichia coli. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1817(6), 965-976.
doi:https://doi.org/10.1016/j.bbabio.2011.12.006
Luzzatto, L., Apirion, D., & Schlessinger, D. (1968). Mechanism of action of streptomycin in E. coli:
interruption of the ribosome cycle at the initiation of protein synthesis. Proc Natl Acad Sci U S A,
60(3), 873-880. doi:10.1073/pnas.60.3.873
Maniprasad, P., & Santra, S. (2012). Novel Copper (Cu) Loaded Core-Shell Silica Nanoparticles with
Improved Cu Bioavailability: Synthesis, Characterization and Study of Antibacterial Properties.
Journal of Biomedical Nanotechnology, 8(4), 558-566. doi:10.1166/jbn.2012.1423
Martin, F., & Pollock, H. (2010). MICROSPECTROSCOPY AS A TOOL TO DISCRIMINATE NANO-MOLECULAR
CELLULAR ALTERATIONS IN BIOMEDICAL RESEARCH. In (pp. 285-336).
Mathelie-Guinlet, M., Grauby-Heywang, C., Martin, A., Fevrier, H., Morote, F., Vilquin, A., . . . CohenBouhacina, T. (2018). Detrimental impact of silica nanoparticles on the nanomechanical
properties of Escherichia coli, studied by AFM. Journal of Colloid and Interface Science, 529, 5364. doi:10.1016/j.jcis.2018.05.098
McManus, P. S., Stockwell, V. O., Sundin, G. W., & Jones, A. L. (2002). Antibiotic use in plant agriculture.
Annu Rev Phytopathol, 40, 443-465. doi:10.1146/annurev.phyto.40.120301.093927
Mengual-Macenlle, N., Marcos, P. J., Golpe, R., & Gonzalez-Rivas, D. (2015). Multivariate analysis in
thoracic research. J Thorac Dis, 7(3), E2-6. doi:10.3978/j.issn.2072-1439.2015.01.43
Miller, S. I., & Salama, N. R. (2018). The gram-negative bacterial periplasm: Size matters. PLoS Biol, 16(1),
e2004935. doi:10.1371/journal.pbio.2004935
Misra, S., Sharma, V., & Srivastava, A. K. (2015). Bacterial Polysaccharides: An Overview. In K. G.
Ramawat & J.-M. Mérillon (Eds.), Polysaccharides: Bioactivity and Biotechnology (pp. 81-108).
Cham: Springer International Publishing.
Mouton, J. W., Muller, A. E., Canton, R., Giske, C. G., Kahlmeter, G., & Turnidge, J. (2017). MIC-based
dose adjustment: facts and fables. Journal of Antimicrobial Chemotherapy, 73(3), 564-568.
doi:10.1093/jac/dkx427
Movasaghi, Z., Rehman, S., & ur Rehman, D. I. (2008). Fourier Transform Infrared (FTIR) Spectroscopy of
Biological Tissues. Applied Spectroscopy Reviews, 43(2), 134-179.
doi:10.1080/05704920701829043
Nanninga, N. (1988). Growth and form in microorganisms: morphogenesis of Escherichia coli. Can J
Microbiol, 34(4), 381-389. doi:10.1139/m88-069
Nicoletti, P., Lenk, R., Popescu, M., & Swenson, C. (1989). Efficacy of various treatment regimens, using
liposomal streptomycin in cows with brucellosis. American journal of veterinary research, 50(7),
1004-1007.
Olkin, I., & Sampson, A. R. (2001). Multivariate Analysis: Overview. In N. J. Smelser & P. B. Baltes (Eds.),
International Encyclopedia of the Social & Behavioral Sciences (pp. 10240-10247). Oxford:
Pergamon.
Papanastasiou, M., Orfanoudaki, G., Koukaki, M., Kountourakis, N., Sardis, M. F., Aivaliotis, M., . . .
Economou, A. (2013). The Escherichia coli peripheral inner membrane proteome. Mol Cell
Proteomics, 12(3), 599-610. doi:10.1074/mcp.M112.024711
Prado Barragán, L. A., Figueroa, J. J. B., Rodríguez Durán, L. V., Aguilar González, C. N., & Hennigs, C.
(2016). Chapter 7 - Fermentative Production Methods. In P. Poltronieri & O. F. D'Urso (Eds.),
Biotransformation of Agricultural Waste and By-Products (pp. 189-217): Elsevier.

44

Qureshi, Z. A., Hittle, L. E., O'Hara, J. A., Rivera, J. I., Syed, A., Shields, R. K., . . . Doi, Y. H. (2015). ColistinResistant Acinetobacter baumannii: Beyond Carbapenem Resistance. Clinical Infectious Diseases,
60(9), 1295-1303. doi:10.1093/cid/civ048
Rashid, S., Long, Z., Singh, S., Kohram, M., Vashistha, H., Navlakha, S., . . . Bar-Joseph, Z. (2019).
Adjustment in tumbling rates improves bacterial chemotaxis on obstacle-laden terrains.
Proceedings of the National Academy of Sciences, 116(24), 11770-11775.
doi:10.1073/pnas.1816315116
Rehm, S. J., & Weber, J. T. (2007). The Far-Reaching Impact of Antimicrobial Resistance. Clinical
Infectious Diseases, 45(Supplement_2), S97-S98. doi:10.1086/519260
Ren, Y., Ji, Y., Teng, L., & Zhang, H. (2017). Using Raman spectroscopy and chemometrics to identify the
growth phase of Lactobacillus casei Zhang during batch culture at the single-cell level. Microbial
cell factories, 16(1), 233-233. doi:10.1186/s12934-017-0849-8
Reyes, V. E., Suárez, G., Sierra, J. C., & Beswick, E. J. (2009). Chapter 50 - Helicobacter pylori. In A. D. T.
Barrett & L. R. Stanberry (Eds.), Vaccines for Biodefense and Emerging and Neglected Diseases
(pp. 983-1012). London: Academic Press.
Rollauer, S. E., Sooreshjani, M. A., Noinaj, N., & Buchanan, S. K. (2015). Outer membrane protein
biogenesis in Gram-negative bacteria. Philos Trans R Soc Lond B Biol Sci, 370(1679).
doi:10.1098/rstb.2015.0023
Rösch, P., Harz, M., Schmitt, M., Peschke, K.-D., Ronneberger, O., Burkhardt, H., . . . Popp, J. (2005).
Chemotaxonomic Identification of Single Bacteria by Micro-Raman Spectroscopy: Application to
Clean-Room-Relevant Biological Contaminations. Applied and Environmental Microbiology,
71(3), 1626. doi:10.1128/AEM.71.3.1626-1637.2005
Rowlett, V. W., Mallampalli, V. K. P. S., Karlstaedt, A., Dowhan, W., Taegtmeyer, H., Margolin, W., &
Vitrac, H. (2017). Impact of Membrane Phospholipid Alterations in <span class="named-content
genus-species" id="named-content-1">Escherichia coli</span> on Cellular Function and
Bacterial Stress Adaptation. Journal of Bacteriology, 199(13), e00849-00816.
doi:10.1128/jb.00849-16
Santo-Domingo, J., Chareyron, I., Broenimann, C., Lassueur, S., & Wiederkehr, A. (2017). Antibiotics
induce mitonuclear protein imbalance but fail to inhibit respiration and nutrient activation in
pancreatic beta-cells. Experimental Cell Research, 357(2), 170-180.
doi:10.1016/j.yexcr.2017.05.013
Sapers, H. M., Hollis, J. R., Bhartia, R., Beegle, L. W., Orphan, V. J., & Amend, J. P. (2019). The Cell and the
Sum of Its Parts: Patterns of Complexity in Biosignatures as Revealed by Deep UV Raman
Spectroscopy. Frontiers in Microbiology, 10. doi:10.3389/fmicb.2019.00679
Shallcross, L. J., & Davies, D. S. (2014). Antibiotic overuse: a key driver of antimicrobial resistance. Br J
Gen Pract, 64(629), 604-605. doi:10.3399/bjgp14X682561
Silhavy, T. J., Kahne, D., & Walker, S. (2010). The bacterial cell envelope. Cold Spring Harb Perspect Biol,
2(5), a000414. doi:10.1101/cshperspect.a000414
Stahle, J., & Widmalm, G. (2019). Lipopolysaccharides of Gram-Negative Bacteria: Biosynthesis and
Structural Aspects. Trends in Glycoscience and Glycotechnology, 31(184), E159-E171.
doi:10.4052/tigg.1749.7E
Sun, Z. Q., Xiong, T. T., Zhang, T., Wang, N. F., Chen, D., & Li, S. S. (2019). Influences of zinc oxide
nanoparticles on Allium cepa root cells and the primary cause of phytotoxicity. Ecotoxicology,
28(2), 175-188. doi:10.1007/s10646-018-2010-9

45

Sunde, M., & Norstrom, M. (2005). The genetic background for streptomycin resistance in Escherichia
coli influences the distribution of MICs. Journal of Antimicrobial Chemotherapy, 56(1), 87-90.
doi:10.1093/jac/dki150
Talari, A. C. S., Movasaghi, Z., Rehman, S., & Rehman, I. u. (2015). Raman Spectroscopy of Biological
Tissues. Applied Spectroscopy Reviews, 50(1), 46-111. doi:10.1080/05704928.2014.923902
Thummeepak, R., Kitti, T., Kunthalert, D., & Sitthisak, S. (2016). Enhanced Antibacterial Activity of
Acinetobacter baumannii Bacteriophage OABP-01 Endolysin (LysABP-01) in Combination with
Colistin. Frontiers in Microbiology, 7. doi:10.3389/fmicb.2016.01402
Tiwari, V., Mishra, N., Gadani, K., Solanki, P. S., Shah, N. A., & Tiwari, M. (2018). Mechanism of Antibacterial Activity of Zinc Oxide Nanoparticle Against Carbapenem-Resistant Acinetobacter
baumannii. Front Microbiol, 9, 1218. doi:10.3389/fmicb.2018.01218
Vaara, M. (2019). Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics.
Molecules, 24(2), 15. doi:10.3390/molecules24020249
Wahab, R., Mishra, A., Yun, S. I., Kim, Y. S., & Shin, H. S. (2010). Antibacterial activity of ZnO
nanoparticles prepared via non-hydrolytic solution route. Appl Microbiol Biotechnol, 87(5),
1917-1925. doi:10.1007/s00253-010-2692-2
Wang, H., Feng, H., Liang, W., Luo, Y., & Malyarchuk, V. (2009). Effect of surface roughness on retention
and removal of Escherichia coli O157:H7 on surfaces of selected fruits. J Food Sci, 74(1), E8-e15.
doi:10.1111/j.1750-3841.2008.00998.x
Wang, H., Jiang, Y. J., Zhang, Y. S., Zhang, Z. W., Yang, X. Y., Ali, M. A., . . . Man, C. X. (2018). Silver
nanoparticles: A novel antibacterial agent for control of Cronobacter sakazakii. Journal of Dairy
Science, 101(12), 10775-10791. doi:10.3168/jds.2018-15258
Wang, L. L., Hu, C., & Shao, L. Q. (2017). The antimicrobial activity of nanoparticles: present situation and
prospects for the future. International Journal of Nanomedicine, 12, 1227-1249.
doi:10.2147/ijn.S121956
Wei, C., Li, M., & Zhao, X. (2018). Surface-Enhanced Raman Scattering (SERS) With Silver Nano
Substrates Synthesized by Microwave for Rapid Detection of Foodborne Pathogens. Frontiers in
Microbiology, 9(2857). doi:10.3389/fmicb.2018.02857
Xie, Y., He, Y., Irwin, P. L., Jin, T., & Shi, X. (2011). Antibacterial Activity and Mechanism of Action of Zinc
Oxide Nanoparticles against <em>Campylobacter jejuni</em>. Applied and Environmental
Microbiology, 77(7), 2325-2331. doi:10.1128/aem.02149-10
Yamamoto, Y., Kawahara, R., Fujiya, Y., Sasaki, T., Hirai, I., Khong, D. T., . . . Nguyen, B. X. (2019). Wide
dissemination of colistin-resistant Escherichia coli with the mobile resistance gene mcr in
healthy residents in Vietnam. Journal of Antimicrobial Chemotherapy, 74(2), 523-524.
doi:10.1093/jac/dky435
Yin, M. L., Li, Z. H., Ju, E. G., Wang, Z. Z., Dong, K., Ren, J. S., & Qu, X. G. (2014). Multifunctional
upconverting nanoparticles for near-infrared triggered and synergistic antibacterial resistance
therapy. Chemical Communications, 50(72), 10488-10490. doi:10.1039/c4cc04584j
Young, O., Lee, Maxwell, Rajasekaran, Beazley, Tetard, Santra. (2019). N-acetyl cysteine coated gallium
particles demonstrate high potency against Pseudomonas aeruginosa. MDPI Pathogens.

46

